Meet the impact innovators building ventures at Zinc. Introducing Dr Suzanne Eldridge, co-founder, with Professor Francesco Dell'Accio, of ReFleks

Congratulations to Suzanne Eldridge for winning best pitcher at BIA

https://t.co/Abff4WTMwv

Excited for our team to be part of the new @ARPA_H NITRO program to develop new therapies for osteoarthritis! https://t.co/NsMPSMk4Rb @setton_lab @ErikHerzog @WashUBME @wustlcrm @ShrinersStLouis @washu_ortho_res @WUSTL_Rheum @WashUGenetics @Guilak_Lab @WUSTLortho

Congratulations to our winners: @DrTinaSmith, @Tap_Track, Sophie Richter and AIKNIT, Suzanne Eldrige and Refleks. 'I loved the human-centred approach to all the innovations…I am leaving more energised than when I came” - Stella Peace 🧵(3/4)

We are recruiting a post doc with strong biochemistry background to generate a new therapeutic for disease modification in osteoarthritis. Please apply here https://t.co/T5K8rpDqwP. Only 24h left.

We are recruiting a post-doc to generate a OA therapeutic suitable for human use. It comes with a generous salary and the project is highly translational. Please apply here

We are recruiting a PhD student to develop a ROR2 inhibitor suitable for human use. This studentship (3+1 year) is funded by Versus Arthritis Interesting candidates will find more information and the application form here:

🎉Congratulations to our 2023 Award Winners!🎉 Please join us today at 5:30pm at the Opening Ceremony to recognize them. #OARSI2023 Suzanne Eldridge, PhD is the recipient of the Rising Star Award, Basic Science.

Technician position advertised with us at https://t.co/SWwT9OaSb8 to study molecular mechanisms of pain in osteoarthritis

We are recruiting a technician on a grant looking in the molecular mechanisms of pain in arthritis! Advert and application form are found here: https://t.co/I6CHrF7Uiu Please circulate this to anyone interested

Today Melody Deniz will present her data on technologies for long-lasting ROR2 knockdown within the joint as a therapy for osteoarthritis at the European Society of Gene and Cell Therapy annual congress in Edinburgh #ESGCT22. Check out her poster Poster no.: P692

I would like to congratulate Suzanne Eldridge for her tenure and promotion to Senior Lectured at @QMUL. Well deserved. I am proud for having been her mentor for so many years.

Join our next Arthritis Web Seminar Series Lecture on June 14, at 8am by Dr. Rik Lories, Head of the Div of Rheum @UZLeuven & of @DevReg_KULeuven, who will present on “Molecular identity of the articular chondrocyte to prevent and treat OA” → https://t.co/NP3FddHSYP PC: 908525

It has been a fantastic #EULAR2022 and we are incredibly happy that our department @EMR_QMUL has had many opportunities to share our science 🧪🧫🧬with you! 👇Here is a photo summary of all our team thorough the various session, from posters, to oral talks to chairing!

Enjoying a great talk by Maurizio Pacifici - @danielle_rux wonderful data! #EULAR2022 #stemcells #cartilage

Abstract submission deadline for our Cutting Edge OA conference is next Monday, 6th of June! Don't miss out on this exciting line-up of speakers! Register until the 24th of June!

Great day in London yesterday when @OACentreOxford came to visit! @WannAngus @QMULWHRI @QMUL @UniofOxford @VersusArthritis

We have a fully funded #PhD project to develop a drug blocking ROR2 for disease modification in osteoarthritis, with a bioinformatics component. Join us in London! Apply by 20th July https://t.co/KPsauTPpaQ #osteoarthritis #cartilagebiology #bioinformatics @QMUL @VersusArthritis

📢Our latest paper is out - we're excited to share this model with the everyone! #osteoarthritis #cartilagerepair #regeneration #drugdevelopment #protocol https://t.co/A0D0VkrBvX